Your Expert Resource for COVID-19 Testing
The complete suite of assays & services needed to detect and characterize responses to SARS-CoV-2.
As experts in clinical assays, PZ Agapiou Diagnostiki Lemesou delivers robust data sets and comprehensive data interpretation beyond what a typical diagnostic lab can offer.
We also offer the breadth of testing needed to determine disease state, characterize antibody response, and assess biomarkers related to SARS-CoV-2, the virus associated with COVID-19.
Our assays are helping the community address the immediate threats of COVID-19 and also look ahead at how patients with antibodies to SARS-CoV-2 might impact the course of the pandemic.
IMMUNE RESPONSE TESTING FOR COVID-19 ANTIBODIES
PZA Lab’s highly specific immune response assays detect, Receptor Binding Domain Abs , Neutralising Abs, Covid 19 IgM, and IgG antibodies to identify individuals who were infected and have already recovered from COVID-19.
The detection of antibodies against SARS-CoV-2 supports:
– Patient Stratification for Clinical Trials
– Vaccine Clinical Trials Support
Why PZ Agapiou Diagnostiki Lemesou for your antibody testing needs?
In addition to qualitative assessments, we are also able to provide semi-quantitative measurements (titer) to assess a patient’s relative levels (magnitude of the response) which indicate stage of infection and strength of antibody response.
DELIVERING A COMPLETE PACKAGE OF COVID-19 TESTING
We’re committed to applying our specialized expertise and proven processes to help our customers test for and understand the impacts of the novel COVID-19 disease. And with fully operational labs, we’re ready to help today.
To discuss your program requirements, contact your PZA Lab representative or reach out to us and we’ll connect you to the appropriate scientists to get started.
Cyprus: 7007 0404 | Limassol: 25 381 373